Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

Completed · Phase 3 · Has a placebo group

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of aspirin may be an effective way to prevent the recurrence of polyps in colorectal cancer. PURPOSE: Randomized phase III trial to study the effectiveness of aspirin in treating patients who have stage I, stage II, or stage III colorectal cancer that has been surgically removed.

Key facts

Study ID
NCT00002527
Run by
Alliance for Clinical Trials in Oncology
People needed
635
Starts
1993-05-01
Expected to finish
2006-01-01
Last updated by the study team
2016-07-04

Who can join

Age: 30 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.